| ORASURE TECHNOLOGIES |
| USA |
| Gesundheit |
| US68554V1089 / 881351 |
| EP3 (Frankfurt) / OSUR (NASDAQ) |
| FRA:EP3, ETR:EP3, EP3:GR, NASDAQ:OSUR |
| - |
| https://orasure.com/ |
|
Orasure Technologies Inc. is a biotechnology company primarily focused on developing point-of-care diagnostic testing and specimen collection devices. Known for its innovation in oral fluid diagnostics, Orasure provides critical solutions in the heal..
>Volltext.. |
| 232.5 Mio. EUR |
| 114.25 Mio. EUR |
| 99.13 Mio. EUR |
| -57.59 Mio. EUR |
| -65.84 Mio. EUR |
| -0.91 EUR |
| 35.49 Mio. EUR |
| 155.22 Mio. EUR |
| -37.88 Mio. EUR |
| 4.01 |
| -34.53% |
| -119.96% |
| - |
| - |
| - |
| - |
| ORASURE |
| 22.07.26 |